Showing 2,921–2,940 of 18,047 drug recalls
Drug Recall
Ongoing
Historical record Class II
Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703. by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1 by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1 by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9 by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703 by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9 by Preferred Pharmaceuticals, Inc.
Reason
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Recall initiated
March 23, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Terminated
Historical record Class III
Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Carton NDC 0093-7487-56, Packet NDC 0093-7487-19 by Teva Pharmaceuticals USA Inc
Reason
Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A. Recall initiated
March 27, 2023 Reported by FDA
April 12, 2023 Distribution
USA Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-121-60. by Direct Rx
Reason
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Recall initiated
March 22, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534. by Direct Rx
Reason
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Recall initiated
March 22, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0240-30. by Direct Rx
Reason
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Recall initiated
March 22, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. by Preferred Pharmaceuticals, Inc.
Reason
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Recall initiated
March 27, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. by Preferred Pharmaceuticals, Inc.
Reason
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Recall initiated
March 27, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3 by Preferred Pharmaceuticals, Inc.
Reason
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Recall initiated
March 27, 2023 Reported by FDA
April 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701 by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00 by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00 by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00 by RemedyRePack Inc.
Reason
cGMP Deviations Recall initiated
March 20, 2023 Reported by FDA
April 12, 2023 Distribution
RemedyRepack distributed product to consignees nationwide within the United States
View recall →
Data last updated: November 2, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
